CO6300950A2 - Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4) - Google Patents

Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)

Info

Publication number
CO6300950A2
CO6300950A2 CO10117060A CO10117060A CO6300950A2 CO 6300950 A2 CO6300950 A2 CO 6300950A2 CO 10117060 A CO10117060 A CO 10117060A CO 10117060 A CO10117060 A CO 10117060A CO 6300950 A2 CO6300950 A2 CO 6300950A2
Authority
CO
Colombia
Prior art keywords
channel
current
channels
blocks
compound
Prior art date
Application number
CO10117060A
Other languages
English (en)
Spanish (es)
Inventor
Kenji Tsujimae
Toshiyuki Onogawa
Shinichi Taira
Hokuto Yamabe
Masataka Ueda
Kuninori Tai
Takashi Oshiyama
Yasuhiro Menjo
Shuuji Matsumura
Yasuo Yoga
Sunao Nakayama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CO6300950A2 publication Critical patent/CO6300950A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO10117060A 2008-02-22 2010-09-22 Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4) CO6300950A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008041296 2008-02-22
JP2008227368 2008-09-04

Publications (1)

Publication Number Publication Date
CO6300950A2 true CO6300950A2 (es) 2011-07-21

Family

ID=40600203

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10117060A CO6300950A2 (es) 2008-02-22 2010-09-22 Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)

Country Status (26)

Country Link
US (2) US8338406B2 (https=)
EP (1) EP2254873B1 (https=)
JP (1) JP5355582B2 (https=)
KR (1) KR101332948B1 (https=)
CN (2) CN101952259B (https=)
AR (1) AR070449A1 (https=)
AU (1) AU2009216079B2 (https=)
BR (1) BRPI0908132A2 (https=)
CA (1) CA2715872A1 (https=)
CO (1) CO6300950A2 (https=)
CY (1) CY1115220T1 (https=)
DK (1) DK2254873T3 (https=)
ES (1) ES2494366T3 (https=)
HR (1) HRP20140796T1 (https=)
IL (1) IL207276A (https=)
MX (1) MX2010009269A (https=)
MY (1) MY156226A (https=)
NZ (1) NZ587157A (https=)
PL (1) PL2254873T3 (https=)
PT (1) PT2254873E (https=)
RU (1) RU2496775C2 (https=)
SI (1) SI2254873T1 (https=)
TW (1) TWI413522B (https=)
UA (1) UA103018C2 (https=)
WO (1) WO2009104819A1 (https=)
ZA (1) ZA201005469B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2494366T3 (es) 2008-02-22 2014-09-15 Otsuka Pharmaceutical Co., Ltd. Compuesto de benzodiacepina y composición farmacéutica
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8796447B2 (en) 2009-08-21 2014-08-05 Otsuka Pharmaceutical Co., Ltd. Process for producing benzo[B][1,4]diazepine-2,4-dione compound
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
CA2834548C (en) 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibitors of histone deacetylase
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
JP2014533258A (ja) 2011-11-15 2014-12-11 ゼンション・リミテッドXention Limited カリウムチャネル阻害剤としてのチエノ[2,3−c]ピラゾールの使用
EP2877444B1 (en) 2012-07-27 2020-09-02 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JOP20190086A1 (ar) * 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA038455B1 (ru) * 2016-10-26 2021-08-31 Новартис Аг Новые производные нафтиридинона и их применение в лечении аритмии
RU2764243C2 (ru) 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
AU2018352142B2 (en) 2017-10-18 2022-08-25 Jubilant Epipad LLC Imidazo-pyridine compounds as PAD inhibitors
US11629135B2 (en) 2017-11-06 2023-04-18 Jubilant Prodell Llc Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
PT3704120T (pt) 2017-11-24 2024-07-03 Jubilant Episcribe Llc Compostos heterocíclicos como inibidores de prmt5
EP3737362B1 (en) 2018-01-12 2025-10-15 Kdac Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
MX2020009517A (es) 2018-03-13 2021-01-20 Jubilant Prodel LLC Compuestos biciclicos como inhibidores de la interaccion/activacio n de pdl/pd-l1.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
BE707667A (https=) 1966-12-14 1968-06-07
JPH0296133A (ja) * 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
BR9200951A (pt) 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
NZ532463A (en) * 2001-11-13 2007-02-23 Dimensional Pharm Inc Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
PL377314A1 (pl) 2002-12-20 2006-01-23 Amgen Inc. Modulatory astmy i zapaleń na tle alergicznym
AR055203A1 (es) 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
ES2494366T3 (es) 2008-02-22 2014-09-15 Otsuka Pharmaceutical Co., Ltd. Compuesto de benzodiacepina y composición farmacéutica

Also Published As

Publication number Publication date
CY1115220T1 (el) 2017-01-04
CA2715872A1 (en) 2009-08-27
ZA201005469B (en) 2011-11-30
HRP20140796T1 (hr) 2014-10-24
PT2254873E (pt) 2014-08-29
US8664217B2 (en) 2014-03-04
MY156226A (en) 2016-01-29
JP5355582B2 (ja) 2013-11-27
AU2009216079B2 (en) 2013-08-22
RU2496775C2 (ru) 2013-10-27
RU2010138928A (ru) 2012-03-27
JP2011512324A (ja) 2011-04-21
AU2009216079A1 (en) 2009-08-27
US8338406B2 (en) 2012-12-25
KR20100124781A (ko) 2010-11-29
TWI413522B (zh) 2013-11-01
US20130040941A1 (en) 2013-02-14
ES2494366T3 (es) 2014-09-15
EP2254873B1 (en) 2014-06-04
NZ587157A (en) 2012-05-25
TW200940067A (en) 2009-10-01
CN101952259B (zh) 2013-07-03
AR070449A1 (es) 2010-04-07
BRPI0908132A2 (pt) 2015-08-04
CN103554088B (zh) 2016-02-24
WO2009104819A1 (en) 2009-08-27
US20100331317A1 (en) 2010-12-30
HK1145461A1 (en) 2011-04-21
MX2010009269A (es) 2010-09-14
PL2254873T3 (pl) 2014-10-31
CN103554088A (zh) 2014-02-05
DK2254873T3 (da) 2014-06-30
SI2254873T1 (sl) 2014-07-31
IL207276A (en) 2014-11-30
IL207276A0 (en) 2010-12-30
EP2254873A1 (en) 2010-12-01
UA103018C2 (uk) 2013-09-10
KR101332948B1 (ko) 2014-01-17
CN101952259A (zh) 2011-01-19

Similar Documents

Publication Publication Date Title
CO6300950A2 (es) Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)
CO6440511A2 (es) Compuesto que contienen nitrogeno y composicion farmaceutica
CO2019000686A2 (es) Compuestos de indol sustituidos con [1,2,4]triazolo[1,5-a]piridinilo
DOP2011000217A (es) Nuevas bencenosulfonamidas como bloqueadores de canales de calcio
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
GT200500185A (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
ATE527693T1 (de) Feldeffekttransistor mit einer oxydschicht als kanalschicht und verfahren zu dessen herstellung
CO2017007635A2 (es) Nuevos compuestos bicíclicos
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
ME01532B (me) Jedinjenja
CO6561782A2 (es) Polipetidos factor viii-fc quimericos e hibridos y metodos de uso de los mismos
PE20121065A1 (es) Compuestos tetraciclicos
MX2019009763A (es) Metodos para tratar esquizofrenia.
PA8795601A1 (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
CL2008002767A1 (es) Compuestos derivados de heterociclico triciclico; composicion farmaceutica; y su uso para el tratamiento de un trastorno mediado por serotonina tal como obesidad, esquizofrenia y disfuncion cognitiva.
AR099071A1 (es) Antagonistas selectivos de nr2b
BRPI0412629A (pt) método de tratamento de disfunção ocular em mamìferos
PA8790101A1 (es) Derivados de aminoalquilazol como antagonistas de histamina-3
CU23853B1 (es) Pirimidinil-piperazinas útiles como ligandos del receptor d3/d2
CL2007000773A1 (es) Uso de compuestos derivados de diazepina condensada para el tratamiento de un desorden cognitivo como add o adhd;o su uso para tratar spm o pmdd.
CO6280532A2 (es) Derivados de isoquinolinona como antagonistas de nk3
CR20110348A (es) Derivados de piperidina
ES2533990T3 (es) Antagonistas de receptores opioides de arilpiperazina
CL2008003932A1 (es) Compuestos derivados de 2-heteroaroil-imidazo[1,2-a]piridina, moduladores de los receptores nucleares nurr1; compuestos intermediarios; composicion farmaceutica; y uso par el tratamiento y prevencion de enfermedades neurodegenerativas, psiquiatricas, inflamatorias, osteoporosis, cancer, entre otras.

Legal Events

Date Code Title Description
FG Application granted